Sitemap | Feedback

Advanced search

Journal of Case Reports

Article Statistics

Case Report

Hypertension with Metabolic Alkalosis and Hypokalaemia - Could it be Aldosterone?
James Cheng Jiang¹, Ronald Castelino^2,3, Surjit Tarafdar^1,4,5 ¹Acute Medical Unit and Departments of ³Pharmacy and ⁴Renal Medicine, Blacktown Hospital, NSW 2148, Australia; ²Faculty of Medicine and Health, University of Sydney, NSW 2148, Australia; ⁵School of Medicine, Western Sydney University, Sydney, Australia.

Number of times this article was viewed	2594
Number of times this article has been printed from the site	813
Number of times this article has been downloaded from the site	907

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

Last updated on Jul 03, 2024

Androxal Medication Case Reports Journal

abortion pill online